Current Drug Therapy

Nziavake Masimasi, MD
Women’s Health Fellow, Cleveland Clinic Women’s Health Center, Department of General Internal Medicine, Cleveland Clinic

Mala S. Sivanandy, MD
Women’s Health Fellow, Cleveland Clinic Women’s Health Center, Department of General Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD
Director, Cleveland Clinic Women’s Health Center; Associate Professor of Surgery, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University

Address: Holly L. Thacker, MD, Women’s Health Center, A10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: thackeh@ccf.org

Nziavake Masimasi, MD
Women’s Health Fellow, Cleveland Clinic Women’s Health Center, Department of General Internal Medicine, Cleveland Clinic

Mala S. Sivanandy, MD
Women’s Health Fellow, Cleveland Clinic Women’s Health Center, Department of General Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD
Director, Cleveland Clinic Women’s Health Center; Associate Professor of Surgery, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University

Address: Holly L. Thacker, MD, Women’s Health Center, A10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: thackeh@ccf.org

Nziavake Masimasi, MD
Women’s Health Fellow, Cleveland Clinic Women’s Health Center, Department of General Internal Medicine, Cleveland Clinic

Mala S. Sivanandy, MD
Women’s Health Fellow, Cleveland Clinic Women’s Health Center, Department of General Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD
Director, Cleveland Clinic Women’s Health Center; Associate Professor of Surgery, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University

Address: Holly L. Thacker, MD, Women’s Health Center, A10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: thackeh@ccf.org

Carlos J. Lozada, MD
Associate Professor of Medicine, University of Miami Miller School of Medicine; Director, Rheumatology Fellowship Program, and Rheumatology Clinical Services, Jackson Memorial Hospital, Miami, FL

Address: Carlos J. Lozada, MD, 1400 NW 10th Avenue, Suite 906, Miami, FL 33136; e-mail: clozada@med.miami.edu

Dr. Lozada has indicated that he has received honoraria from Abbott and Wyeth corporations.

Carlos J. Lozada, MD
Associate Professor of Medicine, University of Miami Miller School of Medicine; Director, Rheumatology Fellowship Program, and Rheumatology Clinical Services, Jackson Memorial Hospital, Miami, FL

Address: Carlos J. Lozada, MD, 1400 NW 10th Avenue, Suite 906, Miami, FL 33136; e-mail: clozada@med.miami.edu

Dr. Lozada has indicated that he has received honoraria from Abbott and Wyeth corporations.

Carlos J. Lozada, MD
Associate Professor of Medicine, University of Miami Miller School of Medicine; Director, Rheumatology Fellowship Program, and Rheumatology Clinical Services, Jackson Memorial Hospital, Miami, FL

Address: Carlos J. Lozada, MD, 1400 NW 10th Avenue, Suite 906, Miami, FL 33136; e-mail: clozada@med.miami.edu

Dr. Lozada has indicated that he has received honoraria from Abbott and Wyeth corporations.

David M. Lang, MD
Head, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: David M. Lang, MD, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail langd@ccf.org

Dr. Lang has disclosed that he has received honoraria, consulting fees, or other benefits for teaching, speaking, consulting, or conducting research for the AstraZeneca, Centocor, Critical Therapeutics, Genentech, Novartis, GlaxoSmithKline, MedPointe, Merck, Sanofi-Aventis, and Schering-Plough/Key corporations.

David M. Lang, MD
Head, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: David M. Lang, MD, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail langd@ccf.org

Dr. Lang has disclosed that he has received honoraria, consulting fees, or other benefits for teaching, speaking, consulting, or conducting research for the AstraZeneca, Centocor, Critical Therapeutics, Genentech, Novartis, GlaxoSmithKline, MedPointe, Merck, Sanofi-Aventis, and Schering-Plough/Key corporations.

David M. Lang, MD
Head, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: David M. Lang, MD, Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, C22, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail langd@ccf.org

Dr. Lang has disclosed that he has received honoraria, consulting fees, or other benefits for teaching, speaking, consulting, or conducting research for the AstraZeneca, Centocor, Critical Therapeutics, Genentech, Novartis, GlaxoSmithKline, MedPointe, Merck, Sanofi-Aventis, and Schering-Plough/Key corporations.

Lea E. Widdice, MD
Assistant Professor of Pediatrics, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

Jessica A. Kahn, MD, MPH
Associate Professor of Pediatrics, Director, Research Training, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; Steering Committee, National Network for Immunization Information; HPV Expert Advisory Group,World Health Organization

Address: Lea E. Widdice, MD, Division of Adolescent Medicine, MLC 4000, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229; e-mail lea.widdice@cchmc.org

Dr. Kahn has disclosed that she has received a consulting fee from the SciMed and Merck corporations for editing a journal supplement on HPV vaccines.

Lea E. Widdice, MD
Assistant Professor of Pediatrics, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

Jessica A. Kahn, MD, MPH
Associate Professor of Pediatrics, Director, Research Training, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; Steering Committee, National Network for Immunization Information; HPV Expert Advisory Group,World Health Organization

Address: Lea E. Widdice, MD, Division of Adolescent Medicine, MLC 4000, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229; e-mail lea.widdice@cchmc.org

Dr. Kahn has disclosed that she has received a consulting fee from the SciMed and Merck corporations for editing a journal supplement on HPV vaccines.

Lea E. Widdice, MD
Assistant Professor of Pediatrics, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

Jessica A. Kahn, MD, MPH
Associate Professor of Pediatrics, Director, Research Training, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; Steering Committee, National Network for Immunization Information; HPV Expert Advisory Group,World Health Organization

Address: Lea E. Widdice, MD, Division of Adolescent Medicine, MLC 4000, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229; e-mail lea.widdice@cchmc.org

Dr. Kahn has disclosed that she has received a consulting fee from the SciMed and Merck corporations for editing a journal supplement on HPV vaccines.

Thomas G. Fraser, MD
Department of Infectious Diseases, Cleveland Clinic

Christine Hansen, PharmD
Department of Pharmacy, Shands Hospital, Orlando, FL

Jennifer K. Long, PharmD
Department of Pharmacy, Cleveland Clinic

Address: Thomas G. Fraser, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail frasert@ccf.org

Dr. Fraser is a member of the Wyeth Emerging Pathogens speakers’ bureau.

Dr. Long is a member of the Cubist speakers’ bureau and the Pfizer speakers’ bureau. This manuscript was generated without outside funding.

Thomas G. Fraser, MD
Department of Infectious Diseases, Cleveland Clinic

Christine Hansen, PharmD
Department of Pharmacy, Shands Hospital, Orlando, FL

Jennifer K. Long, PharmD
Department of Pharmacy, Cleveland Clinic

Address: Thomas G. Fraser, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail frasert@ccf.org

Dr. Fraser is a member of the Wyeth Emerging Pathogens speakers’ bureau.

Dr. Long is a member of the Cubist speakers’ bureau and the Pfizer speakers’ bureau. This manuscript was generated without outside funding.

Thomas G. Fraser, MD
Department of Infectious Diseases, Cleveland Clinic

Christine Hansen, PharmD
Department of Pharmacy, Shands Hospital, Orlando, FL

Jennifer K. Long, PharmD
Department of Pharmacy, Cleveland Clinic

Address: Thomas G. Fraser, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail frasert@ccf.org

Dr. Fraser is a member of the Wyeth Emerging Pathogens speakers’ bureau.

Dr. Long is a member of the Cubist speakers’ bureau and the Pfizer speakers’ bureau. This manuscript was generated without outside funding.

Mohammad Hassan Pervaiz, MD
Department of Medicine, Michigan State University, East Lansing

Michael G. Dickinson, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Mohamad Yamani, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: Mohammad Hassan Pervaiz, MD, B-301 Clinical Center, Michigan State University, East Lansing, MI 44824; email mohammad.pervaiz@ht.msu.edu

Mohammad Hassan Pervaiz, MD
Department of Medicine, Michigan State University, East Lansing

Michael G. Dickinson, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Mohamad Yamani, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: Mohammad Hassan Pervaiz, MD, B-301 Clinical Center, Michigan State University, East Lansing, MI 44824; email mohammad.pervaiz@ht.msu.edu

Mohammad Hassan Pervaiz, MD
Department of Medicine, Michigan State University, East Lansing

Michael G. Dickinson, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Mohamad Yamani, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: Mohammad Hassan Pervaiz, MD, B-301 Clinical Center, Michigan State University, East Lansing, MI 44824; email mohammad.pervaiz@ht.msu.edu

Gregory B. Collins, MD
Section head, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Mark S. McAllister, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Kamala Adury, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Gregory B. Collins, MD, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, P48, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail colling@ccf.org

Gregory B. Collins, MD
Section head, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Mark S. McAllister, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Kamala Adury, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Gregory B. Collins, MD, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, P48, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail colling@ccf.org

Gregory B. Collins, MD
Section head, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Mark S. McAllister, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Kamala Adury, MD
Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic

Address: Gregory B. Collins, MD, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, P48, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail colling@ccf.org

Byron J. Hoogwerf, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail hoogweb@ccf.org

The author has indicated that he serves on an advisory committee to develop educational materials for the Amylin/Lilly Synergy partnership.

Byron J. Hoogwerf, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail hoogweb@ccf.org

The author has indicated that he serves on an advisory committee to develop educational materials for the Amylin/Lilly Synergy partnership.

Byron J. Hoogwerf, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail hoogweb@ccf.org

The author has indicated that he serves on an advisory committee to develop educational materials for the Amylin/Lilly Synergy partnership.

W.H. Wilson Tang, MD
Section of Heart Failure and Cardiac Transplantation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: W.H. Wilson Tang, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail tangw@ccf.org

Dr. Tang has indicated that he previously served as a consultant for GlaxoSmithKline Pharmaceuticals, Amylin Pharmaceuticals, and F. Hoffmann-La Roche Ltd. He is a member of the speakers’ bureau for Takeda Pharmaceuticals.

W.H. Wilson Tang, MD
Section of Heart Failure and Cardiac Transplantation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: W.H. Wilson Tang, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail tangw@ccf.org

Dr. Tang has indicated that he previously served as a consultant for GlaxoSmithKline Pharmaceuticals, Amylin Pharmaceuticals, and F. Hoffmann-La Roche Ltd. He is a member of the speakers’ bureau for Takeda Pharmaceuticals.

W.H. Wilson Tang, MD
Section of Heart Failure and Cardiac Transplantation, Department of Cardiovascular Medicine, Cleveland Clinic

Address: W.H. Wilson Tang, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail tangw@ccf.org

Dr. Tang has indicated that he previously served as a consultant for GlaxoSmithKline Pharmaceuticals, Amylin Pharmaceuticals, and F. Hoffmann-La Roche Ltd. He is a member of the speakers’ bureau for Takeda Pharmaceuticals.